PHAT Competitors & Alternatives
Compare Phathom Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
PHAT
Main Stock$11.33
Tradestie Score
56
Market Cap
$871.90M
Revenue Growth
0.9%
Analyst Upside
+109.2%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MNMD
Mind Medicine (MindMed) Inc. Common Shares
|
$15.02
|
$938.16M | - | 62 | Compare |
|
ZBIO
Zenas BioPharma, Inc. Common Stock
|
$18.01
|
$931.48M | - | 51 | Compare |
|
RLAY
Relay Therapeutics, Inc. Common Stock
|
$13.03
|
$917.23M | - | 52 | Compare |
|
OCS
Oculis Holding AG Ordinary shares
|
$26.72
|
$910.64M | - | 56 | Compare |
|
BCAX
Bicara Therapeutics Inc. Common Stock
|
$21.92
|
$906.29M | - | 49 | Compare |
|
NBTX
Nanobiotix S.A. American Depositary Shares
|
$33.12
|
$903.54M | - | 56 | Compare |
|
ORKA
Oruka Therapeutics, Inc. Common Stock
|
$73.99
|
$900.91M | - | 59 | Compare |
|
EVMN
EVMN
|
$25.58
|
$900.46M | - | 55 | Compare |
|
GERN
Geron Corp
|
$1.51
|
$899.60M | - | 57 | Compare |
|
ANAB
AnaptysBio, Inc. Common Stock
|
$66.11
|
$894.30M | - | 57 | Compare |
More PHAT Analysis
Data updated: Apr 29, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry